Xencor, Inc. (XNCR)
16.52
-0.54
(-3.19%)
USD |
NASDAQ |
Dec 12, 16:00
16.40
-0.12
(-0.70%)
After-Hours: 20:00
Xencor Research and Development Expense (TTM): 225.67M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 95.29M |
| GT Biopharma, Inc. | 4.026M |
| Nuvalent, Inc. | 308.60M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |